Biomarin Pharmaceutical Inc BMRN:NASDAQ

Last Price$74.94Cboe Real-Time Last Sale as of 9:36AM ET 10/18/21
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.95(1.25%)
Bid (Size)$74.57 (200)
Ask (Size)$75.12 (62)
Day Low / High$74.94 - 75.71
Volume941.00
 

View Biotechnology IndustryPeer Comparison as of 10/18/2021

 

Biomarin Pharmaceutical Inc ( NASDAQ )

Price: $74.94
Change: -0.95 (1.25%)
Volume: 941.00
9:36AM ET 10/18/2021
 
 

Incyte Corp ( NASDAQ )

Price: $65.27
Change: -0.29 (0.44%)
Volume: 557.00
9:36AM ET 10/18/2021
 
 

Novavax Inc ( NASDAQ )

Price: $165.00
Change: +3.05 (1.88%)
Volume: 38.6 K
9:36AM ET 10/18/2021
 
 

Exact Sciences Corp ( NASDAQ )

Price: $97.68
Change: -1.28 (1.29%)
Volume: 1.5 K
9:35AM ET 10/18/2021
 
 

Acceleron Pharma Inc ( NASDAQ )

Price: $172.89
Change: -0.05 (0.03%)
Volume: 500.00
9:30AM ET 10/18/2021
 

Read more news Recent News

65483:65PM ET 12/29/1899 

65483:65PM ET 12/29/1899 

65483:65PM ET 12/29/1899 

65483:65PM ET 12/29/1899 

View all Commentary and Analysis

Tracking Baker Brothers Portfolio - Q2 2021 Update
12:54AM ET 10/05/2021 Seeking Alpha

Ascendis Pharma: A Promising Platform And A Rich Valuation
9:38AM ET 9/10/2021 Seeking Alpha

BioMarin: The New Obstacle To Growth
4:40PM ET 9/09/2021 Seeking Alpha

Wall Street Breakfast: El Salvador Adopts Bitcoin (Podcast)
8:08AM ET 9/07/2021 Seeking Alpha

Company Profile

Business DescriptionBioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA. View company web site for more details
Address770 Lindaro Street
San Rafael, California 94901
Phone+1.415.506.6700
Number of Employees2,849
Chairman & Chief Executive OfficerJean-Jacques Bienaimé
Chief Financial Officer & Executive Vice PresidentBrian R. Mueller
Chief Information OfficerEduardo E. Von Pervieux
President-Worldwide Research & DevelopmentHenry J. Fuchs

Company Highlights

Price Open$75.71
Previous Close$75.89
52 Week Range$71.65 - 92.57
Market Capitalization$13.7 B
Shares Outstanding183.4 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement10/27/2021

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings17.69
Earnings per Share$4.28
Beta vs. S&P 500N/A
Revenue$1.5 B
Net Profit Margin43.64%
Return on Equity20.22%

Analyst Ratings as of 09/08/2021

Buy
16
Overweight
2
Hold
4
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset